Blue Chip Healthcare Marketing has helped pharmaceutical, medical device, OTC, biotech, disease management, clinical trial, and consumer packaged goods companies research, test, launch, and deliver solutions to elevate public health. Partnering with 16 of the top 20 pharmaceutical and biotech companies, Blue Chip Healthcare is a full-service, global resource. The agency's experienced leadership unites healthcare marketing insights with brand building expertise steeped in the consumer sector, a powerful combination that is unmatched in the industry.
Since 1995, Blue Chip Patient Recruitment (bcpatientrecruitment.com) has successfully motivated qualified patients to action across nearly 1,000 clinical trials with a 90%+ success rate in achieving program goals. We are recognized for our scientific approach towards clinical trial marketing, our proprietary evaluation models, our insights and strategy, our agonistic approach to media and outreach, and our breakthrough creative. But most importantly, we are recognized for the intelligence, passion and service displayed by each professional at Blue Chip Patient Recruitment.
Blue Chip Healthcare Marketing leverages brand building, pharmacy, retail marketing and healthcare insights in marketing campaigns ranging from home blood pressure monitoring and cholesterol testing to improving patient compliance to prescription medication therapy.
Blue Chip Healthcare engages in a broad range of direct-to-professional healthcare marketing including detailing, continuing medical education, webinars, trade advertising and public relations.

Thinking about investing in biotechnology and drug development? You just sat down at a high stakes table in Vegas. Though the pharmaceutical industry is as volatile as ever, the reward for picking a winner in life science industry is as alluring as its ever been.

At one point or another, 80% of Internet users have looked online for health information. Social networking sites, blogs and podcasts have opened up two-way communication lines for patients and providers.

The FDA just announced new guidelines that will encourage Pharma companies to collaborate with one another in the development of cancer treatment and infectious diseases.